From: The effect of percutaneous coronary intervention on habitual physical activity in older patients
Acceleration categories | Total | Stable Angina | STEMI | NSTEMI |
---|---|---|---|---|
N = 58 | N = 20 | N = 20 | N = 18 | |
0–40 mg (all days)a | 1280 ± 78 | 1240 ± 92 | 1298 ± 59 | 1305 ± 66 |
40–80 mg (all days)a | 108 ± 45 | 132 ± 50 | 95 ± 35 | 94 ± 41 |
80–120 mg (all days)a | 33 ± 21 | 43 ± 24 | 30 ± 16 | 26 ± 18 |
120–160 mg (all days)a | 11 ± 9 | 15 ± 12 | 10 ± 6 | 8 ± 7 |
160–180 mg (all days)a | 4 ± 3 | 5 ± 4 | 4 ± 2 | 3 ± 3 |
200–240 mg (all days)a | 2 ± 2 | 2 ± 2 | 2 ± 1 | 1 ± 2 |
240–280 mg (all days)a | 1 ± 1 | 1 ± 1 | 1 ± 1 | 1 ± 1 |
280–320 mg (all days)a | 0 ± 1 | 1 ± 1 | 0 ± 0 | 0 ± 1 |
MVPA (1 min/day bouts)a | 10 ± 13 | 15 ± 18 | 7 ± 6 | 6 ± 9 |
MVPA (5 min/day bouts)a | 3 ± 6 | 6 ± 10 | 3 ± 4 | 1 ± 3 |
Average wrist acceleration (ENMO, mg) | 15 ± 5 | 18 ± 6 | 14 ± 4 | 14 ± 4 |
Time accelerometer worn (days) | 7 ± 0 | 7 ± 1 | 7 ± 0 | 7 ± 0 |